
I-Penam1 gm/vial
Incepta Pharmaceuticals Ltd.
Meropenem Trihydrate is a broad-spectrum carbapenem antibiotic administered by intravenous injection or infusion and more.
Meropenem Trihydrate is a broad-spectrum carbapenem antibiotic administered by intravenous injection or infusion, reserved for treatment of serious and often resistant bacterial infections under hospital or close medical supervision.
Meropenem Trihydrate should be used based on culture and sensitivity results whenever possible, and is generally reserved for serious infections or as an alternative when first-line antibiotics are unsuitable.
Meropenem Trihydrate is administered only by intravenous (IV) bolus injection (over approximately 3-5 minutes) or IV infusion (over approximately 15-30 minutes), under medical or hospital supervision. It is not given orally or intramuscularly.
| Indication | Dose | Frequency |
|---|---|---|
| Complicated skin/skin structure infections | 500 mg IV | Every 8 hours |
| Complicated intra-abdominal infections | 1 g IV | Every 8 hours |
| Hospital-acquired pneumonia, septicaemia, severe infections (including those due to Pseudomonas) | 1 g IV | Every 8 hours |
| Bacterial meningitis | 2 g IV | Every 8 hours |
| Indication | Dose | Frequency |
|---|---|---|
| Complicated skin/skin structure infections | 10 mg/kg (max 500 mg) | Every 8 hours |
| Complicated intra-abdominal infections | 20 mg/kg (max 1 g) | Every 8 hours |
| Bacterial meningitis | 40 mg/kg (max 2 g) | Every 8 hours |
Children weighing more than 50 kg should receive adult dosing. Safety and efficacy in infants under 3 months have not been established.
| Creatinine clearance | Dose adjustment |
|---|---|
| >50 mL/min | Standard dose, every 8 hours |
| 26-50 mL/min | Standard dose, every 12 hours |
| 10-25 mL/min | Half the standard dose, every 12 hours |
| <10 mL/min | Half the standard dose, every 24 hours; supplemental dosing after haemodialysis is recommended |
Antibiotic stewardship notice: Take Meropenem Trihydrate exactly as prescribed by your physician; do not stop, extend, skip doses, or share this medicine with others without medical advice.
Most adverse effects with Meropenem Trihydrate are mild to moderate. Commonly reported effects (each in ≤2% of patients) include:
Less common but serious effects include hypersensitivity reactions (see Contraindications and Precautions), Clostridioides difficile-associated diarrhea (see Precautions), seizures and other CNS effects (see Precautions), and rare reports of severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis) and hemolytic anemia. Report any severe or persistent symptoms to your physician promptly.
Meropenem Trihydrate is contraindicated in patients with known hypersensitivity to meropenem or to other carbapenem antibiotics.
It is also contraindicated in patients who have had an anaphylactic reaction to other beta-lactam antibiotics (penicillins, cephalosporins), due to the possibility of cross-sensitivity.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.